Precision Digital Health

Precision Digital Health (PDH) is a clinical research technology company based in Irvine, California, specialising in digital and decentralised clinical trials. The company serves pharmaceutical sponsors and contract research organisations (CROs), helping them operationalise complex trial designs by integrating clinical workflows, managing multi-vendor ecosystems, and capturing real-time patient data. PDH combines knowledge drawn from thousands of clinical trials with validated, regulatory-compliant technology to address fragmented data and vendor challenges that can impede trial progress.

PDH describes itself as a team of experienced clinical research professionals focused on accelerating patient therapy innovation. The company positions its work at the intersection of patient-centric clinical development and real-world data collection, with the stated goal of helping bring therapies to market faster while supporting improved patient outcomes. Its customer base includes sponsors and CROs that rely on PDH to resolve technology challenges in digital and device-based trial environments.

SUMMA™ Technology Platform

• SUMMA™ is PDH's purpose-built, proprietary technology platform designed specifically for clinical trial use.
• The platform is described as flexible, modular, and fully validated, accommodating a wide range of study designs, devices, and vendors.
• Clinical experts contributed to the architecture of SUMMA™, enabling it to be configured to the specific parameters of individual trials.
• The platform is built to maintain full regulatory compliance across configurations.

Core Capabilities and Services

• PDH supports the operationalisation of complex digital and decentralised clinical trials (DCTs).
• The company captures real-time patient data to enable therapeutic differentiation and support value-based care.
• PDH delivers seamlessly integrated clinical workflows, including for multi-device and multi-vendor trial scenarios.
• Published case study materials include documentation of continuous glucose monitor (CGM) device capabilities and multi-device DCT implementations.
• Services are designed to mitigate risk associated with siloed data and fragmented vendor ecosystems.

Compliance, Partnerships, and Infrastructure

• PDH participates in the Data Privacy Framework (DPF), indicating adherence to relevant international data privacy standards.
• The company holds an AWS Partnership, reflecting its use of Amazon Web Services infrastructure.
• Technology and processes are described as validated and regulatory-compliant, relevant to clinical trial regulatory requirements.

Leadership and Governance

• The executive team includes Connie Pearcy (CEO), Thomas Wells (President, Chief Product and Innovation Officer, and Co-Founder), and Jonathan Badgett (President and CFO).
• Additional senior leaders cover clinical operations and project management, data services and client delivery, compliance and quality assurance, software quality assurance and release management, product and application strategy, and IT and information security.
• The Board of Directors includes Patrick Phillips (Chair), Ren Roome (representing Boston Millennia Partners), Thomas Wells (Co-Founder), and Connie Pearcy (CEO).

PDH is headquartered at 15615 Alton Parkway, Suite 450, Irvine, California 92618. The company serves a growing set of sponsors and CROs operating in the digital and device clinical trial space, with a focus on building long-term customer relationships through specialised clinical and technical expertise.